Navigation Links
Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability
Date:12/14/2009

RIVIERA BEACH, Fla., Dec. 14 /PRNewswire/ -- Perry Baromedical, international leader in Hyperbaric Chamber manufacturing for 40 years, announces the launch of the Sigma Elite, with extended patient data capture capability. The advanced technology of the Sigma Elite is available on each monoplace chamber model currently available (www.perrybaromedical.com) and has a Patent Pending.

The Sigma Elite New "Smart Hyperbaric System" includes:

  • Data Capture Via Computerized System for Each Dive
  • Electronic (EMR) Medical Records Interface (Optional)
  • Individualized Patient Profiles
  • Visual Graphs in Real Time with Date & Time Log
  • Touch Screen Interface

According to Glenn Dennis, President/COO of Perry Baromedical, "the Sigma Elite now provides the ability for our chambers to provide Patient Data interface to EMR systems. This capability is unique and is in response to customer demand."

Standard features of the Sigma Elite Control and EMR System are:

  • Customizable Automated Treatment Protocols
  • Manual Treatments Captured for Future Use
  • Pneumatic Backup Control System
  • Analog Manual Set Point and Rate Set
  • Hard Copy of Treatment
  • Electronic Record of Treatment
  • Programmable Air Breath Alerts
  • Standard Treatment Profiles Pre-installed
  • Windows XPE Embedded Operating System
  • Split Screen Auxiliary Capability
  • Patient Record Dive Review

Perry Baromedical Corporation is dedicated to providing safe, cost effective and technologically advanced Hyperbaric Oxygen Chambers. Expertise and advanced technology along with proprietary manufacturing process and global resources, allow us to produce, ship, install and service the finest Hyperbaric Oxygen Chambers worldwide. Perry Baromedical is the only US hyperbaric chamber manufacturer that builds three acrylic monoplace models, dualplace, and multiplace units including the largest acrylic monoplace chamber in the world. www.perrybaromedical.com or call 1-800-741-4376.

SOURCE Perry Baromedical


'/>"/>
SOURCE Perry Baromedical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite ... program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in property taxes a year. In some states—like New York, New Jersey, Massachusetts, ... contrast, many overseas retirement havens have extremely low property-tax rates, which contributes to ...
Breaking Medicine News(10 mins):